Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · IEX Real-Time Price · USD

3.370

-0.230 (-6.39%)

At close: Jul 2, 2024, 4:00 PM

3.460

+0.090 (2.67%)

After-hours: Jul 2, 2024, 7:45 PM EDT

Adaptive Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	497	709	1,093	3,960	8,087	3,720
Market Cap Growth	-63.17%	-35.07%	-72.41%	-51.03%	117.39%	-
Enterprise Value	413	589	825	3,717	7,505	3,178
PE Ratio	-	-3.15	-5.46	-19.10	-55.31	-53.47
PS Ratio	2.85	4.17	5.90	25.66	82.20	43.73
PB Ratio	1.81	2.30	2.35	6.56	10.88	6.52
P/FCF Ratio	-3.22	-4.25	-5.46	-15.56	-48.00	19.16
P/OCF Ratio	-3.44	-4.54	-5.94	-20.55	-54.03	18.11
EV/Sales Ratio	2.37	3.46	4.45	24.08	76.28	37.36
EV/EBITDA Ratio	-2.20	-3.23	-4.92	-19.95	-55.80	-52.25
EV/EBIT Ratio	-1.89	-2.79	-4.21	-17.93	-51.32	-46.32
EV/FCF Ratio	-2.64	-3.53	-4.12	-14.61	-44.54	16.36
Debt / Equity Ratio	0.83	0.74	0.50	0.19	0.15	0.06
Debt / EBITDA Ratio	-1.32	-1.26	-1.39	-0.60	-0.80	-0.60
Debt / FCF Ratio	-1.57	-1.37	-1.17	-0.44	-0.64	0.19
Quick Ratio	4.27	4.40	4.92	3.27	6.66	7.56
Current Ratio	4.51	4.66	5.12	3.54	6.91	7.82
Asset Turnover	0.25	0.23	0.22	0.15	0.10	0.14
Interest Coverage	-15.22	-15.32	-46.24	-	-	-
Return on Equity (ROE)	-64.10%	-60.50%	-39.60%	-31.00%	-22.50%	-44.50%
Return on Assets (ROA)	-31.10%	-30.70%	-23.50%	-20.60%	-14.80%	-11.20%
Return on Capital (ROIC)	-43.46%	-42.21%	-28.70%	-29.20%	-17.95%	-12.90%
Earnings Yield	-43.30%	-31.75%	-18.32%	-5.23%	-1.81%	-1.87%
FCF Yield	-29.16%	-23.54%	-18.33%	-6.43%	-2.08%	5.22%
Buyback Yield / Dilution	-1.59%	-1.31%	-1.54%	-6.96%	-89.71%	-447.64%
Total Shareholder Return	-1.59%	-1.31%	-1.54%	-6.96%	-89.71%	-447.64%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).